Trial intelligence / Profile preview

Deferiprone and/or Desferrioxamine in Iron Overloaded Patients

NCT00350662Phase 3Completed

Sponsor
Lipomed AG
Start
Jan 2002
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of deferiprone in iron overload, sponsored by Lipomed AG. Started Jan 2002; status: completed.

02

Drugs

deferiprone
03

Conditions

iron overload

Beyond the preview

Go deeper on NCT00350662.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00350662.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call